You searched for "enucleation"
Glaucoma UK ‘Excellence in Glaucoma Care Award 2024’ Winner Announcement
PhD student at Glasgow Caledonian University wins the Glaucoma UK ‘Excellence in Glaucoma Care Award 2024’.Ophthalmic surgeon returns to London Marathon after 31 years for Glaucoma UK
Michael Miller, in commemoration of Glaucoma UK's 50th anniversary, has achieved a remarkable feat by completing this year's London Marathon, three decades after he last completed the challenge in 1993, which he also ran in support of the charity.HASA OPTIX Certifies as a B Corporation
Premium recyclable ophthalmic instrument company HASA OPTIX announces its certification as a B Corporation (B Corp) company. In a press release, the Brussels-based scale-up confirmed its score of 109.7 points on the B Impact Assessment, in which nonprofit B Lab...How effective is nurse-led telephone preassessment for cataract surgery?
Cataract surgery is the most frequently performed surgical procedure in the UK [1]. The demand for cataract surgery is projected to increase with ageing population, and the recent pandemic has further contributed to the extended waiting times in the UK....Assessing everyday visual function in dry AMD – what matters to the person?
Age-related macular degeneration (AMD) is the primary cause of blindness in the developed world and is accountable for more than one half of sight impairment registrations within England and Wales [1]. AMD is prevalent in people aged 60 years and...Modern practice options for UK ophthalmologists
When I spoke on setting up private practice at the annual United Kingdom & Ireland Society of Cataract & Refractive Surgeons (UKISCRS) meeting in November ’23 there was a lot of interest in different types of practice models. If we...An eye on novel anti-cancer agents: an evidence-based approach to external eye assessment
Novel anti-cancer therapies have led to significant advancement in cancer treatment, however, they can be associated with external eye complications. It is important to be mindful of such adverse effects during assessment of patients enrolled in clinical trials. Annually, approximately...
Mast cells in Graves’ ophthalmopathy
Graves’ ophthalmopathy (GO) is a potentially sight-threatening ocular disease, occurring in patients with hyperthyroidism due to Graves’ disease. Also known as thyroid-associated ophthalmopathy, GO is characterised by orbital infiltration by immune cells including macrophages, T cells and plasma cells, which...
